Serum Institute, Vidal Health collaborate on facilitating access to HPV vaccines

Vaccine -maker Serum Institute of India and Vidal Health have come together to facilitate access to HPV vaccines, aimed at cervical cancer prevention, starting October 1, 2025.

Touted as the country’s second largest TPA service provider, Vidal Health’s platform will offer an end-to-end, cashless experience for HPV vaccine, a joint note from the companies said. “From digitally booking a doctor’s appointment at a preferred location, to providing consent and receiving certification — all with zero paperwork,” it said.

The fully managed health programme will provide support including dosage reminders, adherence monitoring, and efficient network management to ensure continuity of care, it added.

Vidal Health is a 100 per cent subsidiary of Bajaj Finserv Health, a digital platform that int